Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Furling

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Skeletal Muscle|July 22, 2016
Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal musclePauline Roy, Fredérique Rau, Julien Ochala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2019
Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 MiceMirella Lo Scrudato, Karine Poulard, Célia Sourd, et al.
The Journal of Physiology|July 9, 2024
Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin-desmin double knockout (DKO) mouseDylan Moutachi, Janek Hyzewicz, Pauline Roy, et al.
The Journal of Physiology|June 10, 2020
Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouseArnaud Ferry, Julien Messéant, Ara Parlakian, et al.
Human Gene Therapy|April 11, 2009
Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cellsSoraya Chaouch, Vincent Mouly, Aurélie Goyenvalle, et al.
Cell Death & Disease|October 21, 2018
Activation of the interferon type I response rather than autophagy contributes to myogenesis inhibition in congenital DM1 myoblastsMilena Rizzo, Pascale Beffy, Renata Del Carratore, et al.
The Journal of Clinical Investigation|January 10, 2017
Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type IMarielle Brockhoff, Nathalie Rion, Kathrin Chojnowska, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 18, 2025
Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1Caroline Hermitte, Hortense de Calbiac, Gilles Moulay, et al.
Molecular Neurodegeneration|July 29, 2016
Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteinsSandro Alves, Thibaut Marais, Maria-Grazia Biferi, et al.
Circulation|October 26, 2018
High Risk of Fatal and Nonfatal Venous Thromboembolism in Myotonic DystrophyMaximilien Sochala, Raphaël Porcher, Tanya Stojkovic, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Skeletal Muscle|July 22, 2016
Dystrophin restoration therapy improves both the reduced excitability and the force drop induced by lengthening contractions in dystrophic mdx skeletal musclePauline Roy, Fredérique Rau, Julien Ochala, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2019
Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 MiceMirella Lo Scrudato, Karine Poulard, Célia Sourd, et al.
The Journal of Physiology|July 9, 2024
Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin-desmin double knockout (DKO) mouseDylan Moutachi, Janek Hyzewicz, Pauline Roy, et al.
The Journal of Physiology|June 10, 2020
Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouseArnaud Ferry, Julien Messéant, Ara Parlakian, et al.
Human Gene Therapy|April 11, 2009
Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in Duchenne muscular dystrophy cellsSoraya Chaouch, Vincent Mouly, Aurélie Goyenvalle, et al.
Cell Death & Disease|October 21, 2018
Activation of the interferon type I response rather than autophagy contributes to myogenesis inhibition in congenital DM1 myoblastsMilena Rizzo, Pascale Beffy, Renata Del Carratore, et al.
The Journal of Clinical Investigation|January 10, 2017
Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type IMarielle Brockhoff, Nathalie Rion, Kathrin Chojnowska, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 18, 2025
Alternative Splicing of SORBS1 Affects Neuromuscular Junction Integrity in Myotonic Dystrophy Type 1Caroline Hermitte, Hortense de Calbiac, Gilles Moulay, et al.
Molecular Neurodegeneration|July 29, 2016
Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteinsSandro Alves, Thibaut Marais, Maria-Grazia Biferi, et al.
Circulation|October 26, 2018
High Risk of Fatal and Nonfatal Venous Thromboembolism in Myotonic DystrophyMaximilien Sochala, Raphaël Porcher, Tanya Stojkovic, et al.
Pageof 8